[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

Volume: 18, Issue: 1
Published: Apr 27, 2017
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by an unpredictable course. Prognostic markers and disease activity markers are needed. The purpose of this single-center retrospective study was to evaluate the prognostic value of lung fluorodeoxyglucose ([18F]-FDG) uptake assessed by standardized uptake value (SUV), metabolic lung volume (MLV) and total lesion glycolysis (TLG) in patients with IPF. We included 27 IPF...
Paper Details
Title
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
Published Date
Apr 27, 2017
Volume
18
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.